GLP-1 receptor agonistGLP-1 Agonists
Lixisenatide
A once-daily GLP-1 receptor agonist derived from exendin-4. FDA-approved as Adlyxin for type 2 diabetes. Also available in combination with insulin glargine as Soliqua.
blood-sugar-controlweight-lossFDA-approved
3D Structure
3D Structure
4858.49 Da
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A once-daily GLP-1 receptor agonist derived from exendin-4. FDA-approved as Adlyxin for type 2 diabetes. Also available in combination with insulin glargine as Soliqua.